A majority of US Food and Drug Administration units – 15 out of its 21 offices – will be impacted by a pending reorganization that is currently awaiting clearance from higher ups in the Biden administration, outgoing principal deputy commissioner Janet Woodcock said on 19 January.
‘The Largest Reorganization In FDA’s History’: ORA Overhaul Better Thought Of As Agency-Wide Reorg
US FDA's response time and decision consistency on compliance issues should improve under reorganization that aims to take agency processes into the modern era. FDA is already moving forward on steps needed to implement the reorg as it awaits HHS and White House approval.
